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Background. Cytomegalovirus (CMV) disease is rare in previously immunocompetent patients. We report a case of CMV enteritis
complicated by massive intestinal bleeding. Case History. A 72-year-old immunocompetent patient was admitted for diarrhea and
abdominal pain. Aspeciﬁc pattern of duodenitis was found at abdomen computed tomography and on biopsies during endoscopy.
A diagnosis of vasculitis was suspected on the basis of the clinical and biological course (skin lesions, arthralgias, proteinuria,
low complement C3 and C4 fractions, etc.) and pulse steroid therapy was prescribed. The patient developed multiple episodes
of intestinal bleeding with shock and required urgent laparotomy. Jejunitis due to CMV vasculitis was proven by histological
examination of the operative specimen. Treatment with ganciclovir was initiated. No bleeding recurrence was noted. No other
lesions from CMV infection were observed. The patient died from unrelated complications. Discussion.C M Ve n t e r i t i si sar a r e
cause of intestinal bleeding particularly in previously immunocompetent patients. Aging could be accompanied by a relative
immune weakness and speciﬁc antiviral therapy seems to be indicated.
1.Introduction
Cytomegalovirus (CMV) enteritis is mostly associated with
patients positive for human immunodeﬁciency virus or
immunosuppressed transplant patients. Involvement of
small bowel is rare. We report a case of CMV jejunitis, with-
out colon involvement, complicated by massive intestinal
bleeding in a previously immunocompetent elderly patient.
2.CaseReport
A 72-year-old man was admitted in a ﬁrst hospital for
diﬀuse abdominal pain and diarrhea. This patient had no
historyofmalignancy,HIV,diabetesorotherchronicdisease,
and was never treated by immunosuppressive drugs. He
was chronically treated for Parkinson disease, asbestosis,
paroxystic atrial ﬁbrillation, hyperuricemia and hyperc-
holesterolemia. His current medications were allopurinol,
amiodarone, levodopa and simvastatin. He was not under
antiplatelet or anticoagulant therapy prior to admission. On
physical examination, the patient was apyretic, with supple
abdomen and no rebound tenderness. Peripheral oedema
was noted. Routine laboratory investigations revealed: C-
reactive protein (CRP) 16.4mg/dL, white blood cell count
18,900/mm3, platelet count 530,000/mm3, INR 1.15, ﬁb-
rinogen396mg/dL,proteins3.8g/dL,albumin1.9g/dL,urea
70mg/dL, creatinine 0.80mg/dL. A moderate proteinuria
was noted (1.267g/24hr) without urinary casts.
The patient was investigated by abdomen computed
tomodensitometry (CT) and upper and lower endoscopy.
The abdomen CT with intravenous contrast disclosed a
signiﬁcant thickening of the wall of the third, fourth
duodenum, and of the proximal part of the jejunum with
inﬁltration of the loco-regional fat (Figure 1).
Esogastroscopy revealed a proliferative aspect in the
duodenum. Duodenal biopsy showed an inﬁltration of the
mucosabypolynucleatedcells,butnoulcerationwasevident.
The lower endoscopy was negative.2 Case Reports in Medicine
Figure 1: Abdomen computed tomography after intravenous
contrast. Signiﬁcant thickening of the Treitz angle and proximal
jejunum (arrows), with inﬁltration of the loco-regional fat.
Figure 2: Angiography demonstrating active bleeding (arrow) in
one of the branchs of the jejunal arteries.
A few days later, ecchymotic lesions appeared on the
limbs and the patient started also to complain from diﬀuse
arthralgias and weakness in the upper and lower limbs. Elec-
tromyography was consistent with an acute sensorimotor
polyneuropathy.
Serological investigations revealed: rheumatoid factor
(-), anti-nuclear antibodies (-), anti-neutrophilic cytoplas-
mic antibodies (-), cryoglobulin (-), low C3 and C4 fractions
of complement. Serological tests were negative for hepatitis
B and C, EBV and HIV.
Due to the possibility of a systemic inﬂammatory disease
combining skin lesions, arthralgia, polyneuropathy, protein-
uria, high CRP with low complement fractions, a pulse
steroid therapy was proposed on day 14 for a presumptive
diagnosisofvasculitis,eithermicroscopicpolyangiitis(MPA)
or polyarteritis nodosa (PAN). However, no skin or sural
nerve biopsies were performed. The steroids loading dose
was1gmethylprednisolone,followedby2mg/kg/dayforone
week, and then 4 mg/day.
Figure 3: Microscopic examination (hematoxylin-eosin, x150) of
the operative specimen. Ulcerative ileitis, the mucosa is replaced by
a granulation tissue.
Figure 4: High-power microscopic examination (hematoxylin-
eosin, x400) revealed vasculitis. Some endothelial cells present
cytomegaly, suggestive of CMV infection (arrows). The presence of
CMV in the jejunum was demonstrated by immunohistochemistry
(inset; immunoperoxidase, x400).
The patient was referred to the intensive care unit (ICU)
of our university hospital on day 15 for gastrointestinal
bleeding with melena. Despite blood and platelets trans-
fusions, he remained with a low arterial blood pressure
at 90/65mmHg and hemoglobin concentration remained
below0.4g/dL.Urgentgastroscopyfailedtorevealanylesion.
Angiography demonstrated that the bleeding originated
from a jejunal branch and microcatheter embolization was
successful initially (Figure 2). However, two major episodes
of lower intestinal bleeding occurred again within 48 hours
after the procedure. On day 19, conventional enteroscopy
revealed proximal jejunal ulcer with visible vessel and
endoscopic clipping was performed. During the ICU stay,
the patient was fed by intravenous parenteral nutrition and
received daily intravenous vitamin K1 supplements. Despite
optimization of the coagulation, rebleeding was noted on
day 26 (hemoglobin 0.37g/dL), but abdomen CT and
angiography with direct intra-arterial provocative papaver-
ine administration were not able to identify the origin.
Scintigraphy with 99mTc labeled erythrocytes suggested that
the origin was proximal small bowel. After a recurrence of
hemorrhagic shock on day 28, the patient underwent urgent
laparotomy. Active jejunal bleeding was found leading toCase Reports in Medicine 3
segmental resection. Lower intestinal bleeding was deﬁnitely
stopped after surgery.
Histology of the jejunal resection showed a severe
mucosal necrosis with loss of villi (Figure 3). High-power
examination revealed thrombosis and ﬁbrinoid necrosis sug-
gestive of vasculitis. Some of the endothelial cells presented
the characteristic cytopathogenic aspect of CMV infection
(Figure 4).
CMVantigenemiadeterminedbyreal-timePCRinblood
was weakly positive (5200DNA copies/mL).
Multiple skin biopsies (hands, arms, legs) had also
been performed on day 20. The histological picture was
consistent with a diagnosis of leukocytoclastic vasculitis,
but was not speciﬁc. No CMV inclusion was noted. Direct
immunoﬂuorescence showed deposits of IgG, IgA, IgM and
C3 fraction of complement.
There was no evidence of CMV-related retinitis, pneu-
monia, hepatitis or bone marrow depression; the gastroin-
testinal involvement was restricted to the small bowel.
Ganciclovir (200mg every 12h) was given intravenously
for 14 days to treat CMV disease. CMV antigenemia was
negative at the end of the treatment. The patient had
been maintained on low doses of oral methylprednisolone
(4mg/day);steroidswerediscontinuedafter2months.Other
complications, mainly bacterial pneumonia and sepsis,
occurred during hospital stay. After a signiﬁcant recovery,
the patient was discharged from the ICU on day 58, but died
on day 159 from unrelated cardiorespiratory complications.
Postmortem examination was not obtained.
3. Discussion
CMV enteritis is a rare disease occurring mainly in immuno-
compromised patients. Symptoms of CMV enteritis may
range from mild anorexia to obvious hemorrhage and
perforation. The pathogenesis of CMV enteritis is related to
the infection of vascular endothelial cells [1, 2]. When CMV
infects small bowel, it tends to invade a particular region
rather than becoming a panenteric process [3, 4]. Signs of
CMVvasculitismaybealsoobservedinotherorgans(central
nervous system, lungs, skin, etc.) [5].
A severe CMV disease is possible in patients receiving
immunosuppressive agents for a chronic inﬂammatory dis-
ease, even at relatively low doses [6, 7]. However, in most
of the cases, other medications were given in addition to
steroids and the duration of therapy is long. Our patient
was admitted with clinical manifestations consistent with
gastrointestinal CMV infection, but as in previous cases
of small bowel involvement, the diagnosis was made with
some delay [1, 8]. The patient was not initially tested for
CMV serology. Serologies, however, are not suﬃcient to
make the diagnosis of CMV-associated disease. Viremia can
be detected by PCR, but compartimentalized disease can
occur with minimally detectable or undetectable virus in the
blood. CMV infection could not be demonstrated initially
on duodenal biopsies, but well on the jejunal operative
specimen. Biopsies should be done deep enough to obtain
endothelial cells and ﬁbroblasts within the lamina propria
because the virus may not be present in the more superﬁcial
epithelial tissue. As the clinical, radiological and endoscopic
signs appeared before any steroid therapy, we suspect that a
community-acquired CMV infection or reactivation due to
age-related impaired immunity preceded the short course of
steroid therapy.
The mortality rate of CMV vasculitis is high for
patients in a condition of immunosuppression, while the
prognosis is better for those who are immunocompetent
[8]. Galiatsatos et al. identiﬁed risk factors that might
inﬂuencetheprognosisofCMVcolitisinimmunocompetent
patients [9]. They found only 43 cases from a literature
search performed from 1980 to 2003. There was a higher
mortality among male patients older than 55 years and in
patients with co-existing immune-modulating conditions,
chieﬂy renal failure and diabetes mellitus. Spontaneous
resolution is possible in younger patients, even in the
absence of speciﬁc antiviral therapy. No data are speciﬁcally
available for CMV enteritis, but the risk factors are probably
similar. Our patient had no signiﬁcant co-morbidity, but
we cannot exclude that even a short course of steroids
could have ampliﬁed CMV disease. In a 35-year-old man
who developed fulminant hepatitis from unknown origin,
and who had received pulse steroid therapy followed by
decreasing doses of oral methylprednisolone, small-bowel
hemorrhage due to CMV vasculitis occurred approximately
8 weeks after disease onset and required ileal resection
[10].
The involvement of CMV infection in the other mani-
festations (cutaneous necrotic lesions, arthralgias, neuropa-
thy, proteinuria, etc.) remains speculative [11]. It cannot
be excluded that a systemic vasculitis was triggered by
CMV infection, making important the diﬀerential diagnosis
between virus-associated vasculitis and idiopathic MPA or
PAN [12]. This would result in a less aggressive cytotoxic
treatment for the former manifestations.
In the present observation, testing for anti-nuclear,
anti-neutrophilic cytoplasmic antibodies and cryoglobulin
was negative and the systemic manifestations resolved after
ganciclovir therapy and maintenance of low doses pred-
nisolone. The presence of skin lesions could be a marker
of a poorer prognosis [5]. Cutaneous vasculitis may result
from viral infection of endothelial cells, but as in our case,
vasculitis without local evidence of virus can also be noted;
the presence of immune complexes deposits suggests an
immune-mediated process.
Massive bleeding from CMV-related small-bowel ulcers
is an extremely rare occurrence [13–16]. As in our case,
symptoms preceding hemorrhage or perforation are usu-
ally vague. The ﬁrst report of CMV enteritis causing
segmental ischemia and massive intestinal hemorrhage in
an immunocompromised patient appeared in 2001 [2].
Additionally, small-bowel hemorrhage after CMV ileitis was
diagnosed in a 73-year-old man receiving oral prednisolone
for approximately 2 months to treat nonsystemic vasculitic
neuropathy [17]. Fatality from hemorrhage was also noted
in a 66-year-old man who had only type 2 diabetes as an
immune-modulating condition [14]. Due to the location of
the bleeding, the diagnosis is always diﬃcult and could only
be made either by enteroscopy or angiography.4 Case Reports in Medicine
Ganciclovir remains the treatment of choice of gastroin-
testinal CMV disease in immmunocompromised patients
and no studies have reported the eﬃcacy of foscarnet
in patients without AIDS. However, the overall response
to ganciclovir in immunocompetent patients is unknown.
Withdrawal of immunosuppressive drugs is also essential
when possible.
In conclusion, this case illustrates the diﬃcult early diag-
nosis of segmental CMV enteritis in an immunocompetent
patient and also the risks of high doses steroids therapy when
the apparent diagnosis of vasculitis is only presumptive.
Endoscopic studies with biopsies are essential together with
the determination of CMV antigenemia. The tests must
be repeated if the initial results are inconclusive. Surgical
treatment should remain exceptional in case of massive
gastrointestinal bleeding that could not be controlled by
selective embolization. Due to the high risk of complications
and mortality of CMV enteritis in the elderly, all the patients
must be oﬀered antiviral treatment as soon as possible. The
duration of the treatment should be guided by the clinical
course and by the negativity of CMV antigenemia.
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